• Türkçe
    • English
  • English 
    • Türkçe
    • English
  • Login
View Item 
  •   RTEÜ
  • Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed
  • WoS İndeksli Yayınlar Koleksiyonu
  • View Item
  •   RTEÜ
  • Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed
  • WoS İndeksli Yayınlar Koleksiyonu
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

The effects of TNF-alpha inhibitors on carbon tetrachloride-induced nephrotoxicity

Thumbnail

View/Open

Full Text / Tam Metin (7.987Mb)

Access

info:eu-repo/semantics/closedAccess

Date

2021

Author

Özdemir, Ali
Tümkaya, Levent
Kalcan, Süleyman
Uyan, Mikail
Karakaya, Ahmet
Demiral, Gökhan
Samancı, Tuğba Çelik
Mercantepe, Tolga
Cüre, Medine Cumhur
Cüre, Erkan

Metadata

Show full item record

Citation

Ozdemir, A., Tumkaya, L., Kalcan, S., Uyan, M., Karakaya, A., Demiral, G., Celik Samanci, T., Mercantepe, T., Cumhur Cüre, M., & Cüre, E. (2022). The effects of TNF-α inhibitors on carbon tetrachloride-induced nephrotoxicity. Clinical and experimental hypertension (New York, N.Y. : 1993), 44(3), 291–296. https://doi.org/10.1080/10641963.2021.2018600

Abstract

Objectives: Carbon tetrachloride (CCl4), employed in various industrial fields, can cause acute damage in renal tissues. This study investigated the therapeutic effect of the TNF-alpha inhibitor Infliximab on TGF-beta and apoptosis caused by acute kidney image induced by CCl4. Methods: Twenty-four male Sprague-Dawley rats were assigned into control, CCl4, and CCl4+ Infliximab groups. The control group received an isotonic saline solution, and the CCl4 group 2 mL/kg CCl4 intraperitoneally (i.p). The CC(l)4+ Infliximab group was given 7 mg/kg Infliximab 24 hours after administration of 2 mL/kg CCl4. Kidney tissues were removed at the end of the experiment and subjected to histopathological and biochemical analysis. Results: The application of CCl4 led to tubular necrosis, inflammation, vascular congestion, and increased Serum BUN and creatinine values. An increase in caspase-3 activity also occurred in the CCl4 group. However, Infliximab exhibited an ameliorating effect on kidney injury by causing a decrease in the number of apoptotic cells. Tissue ADA and TGF-beta values of the CCL4 group were significantly higher than the values of the control group (p = .001, p < .001 respectively) and CCL4+ Inf group (p = .004, p = .015, respectively). Conclusions: This study shows that Infliximab ameliorates nephrotoxicity by reducing lipid peroxidation, oxidative stress, and apoptosis in acute kidney damage developing in association with CCI4 administration. These findings are promising in terms of the ameliorating role of TNF-alpha inhibitors in acute kidney injury.

Source

Clinical and Experimental Hypertension

Volume

44

Issue

3

URI

https://doi.org/10.1080/10641963.2021.2018600
https://hdl.handle.net/11436/6545

Collections

  • PubMed İndeksli Yayınlar Koleksiyonu [2443]
  • Scopus İndeksli Yayınlar Koleksiyonu [6011]
  • TF, Cerrahi Tıp Bilimleri Bölümü Koleksiyonu [1223]
  • TF, Temel Tıp Bilimleri Bölümü Koleksiyonu [699]
  • WoS İndeksli Yayınlar Koleksiyonu [5260]



DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 




| Instruction | Guide | Contact |

DSpace@RTEÜ

by OpenAIRE
Advanced Search

sherpa/romeo

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsTypeLanguageDepartmentCategoryPublisherAccess TypeInstitution AuthorThis CollectionBy Issue DateAuthorsTitlesSubjectsTypeLanguageDepartmentCategoryPublisherAccess TypeInstitution Author

My Account

LoginRegister

Statistics

View Google Analytics Statistics

DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 


|| Guide|| Instruction || Library || Recep Tayyip Erdoğan University || OAI-PMH ||

Recep Tayyip Erdoğan University, Rize, Turkey
If you find any errors in content, please contact:

Creative Commons License
Recep Tayyip Erdoğan University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..

DSpace@RTEÜ:


DSpace 6.2

tarafından İdeal DSpace hizmetleri çerçevesinde özelleştirilerek kurulmuştur.